

Lacerta Therapeutics Information
Summary
Lacerta Therapeutics is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology, Medical Research & Laboratories areas. The position of the President & CEO is occupied by Joseph Reddy. Its headquarters is located at Alachua, Florida, USA. The number of employees ranges from 1 to 25. The annual revenue of Lacerta Therapeutics varies between 5.0M and 25M. Total funding of the company - $30.6M. To connect with Lacerta Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
AAV gene therapy, AAV manufacturing, AAV capsid variants, AAV capsid engineering, CNS disease, Lysosomal storage disease
SIC Code
2836, 8731
DMA Code
Gainesville Metropolitan Area
Founded
2017
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2008 | Public Company | 25 - 100 | < 1M | $229.7M | |
2016 | Privately Held | 25 - 100 | < 1M | $407M | |
2001 | Privately Held | 25 - 100 | 5M | $20.2M | |
2015 | Privately Held | 25 - 100 | < 1M | $316.1M | |
2000 | Public Company | 25 - 100 | 40.9M | $119.2M | |
2018 | Privately Held | 10-50 | < 1M | $43.2M | |
2018 | Privately Held | 1-10 | < 1M | $22.5M | |
2015 | Privately Held | 1 - 25 | < 1M | $0 | |
2006 | Privately Held | 1 - 25 | 10M | $0 | |
2016 | Privately Held | 25 - 100 | 4.5M | $0 | |
2015 | Privately Held | 10-50 | < 1M | $0 | |
- | Privately Held | 200-500 | - | $- | |
1961 | - | 100-200 | - | $- | |
2015 | - | 100-200 | - | $- |